| Issue Date | Title | Author(s) |
| 2023-08-15 | Advances in TEER measurements of biological barriers in microphysiological systems. | Nazari, H; Shrestha, J; Naei, VY; Bazaz, SR; Sabbagh, M; Thiery, JP; Warkiani, ME |
| 2022-08 | Application of circulating tumour cells to predict response to treatment in head and neck cancer. | Zhang, X; Ekanayake Weeramange, C; Hughes, BGM; Vasani, S; Liu, ZY; Warkiani, ME; Hartel, G; Ladwa, R; Thiery, JP; Kenny, L; Punyadeera, C |
| 2023-01-01 | Circulating Tumour Cell Isolation and Molecular Profiling; Potential Therapeutic Intervention | Radfar, P; Es, HA; Kulasinghe, A; Thiery, JP; Warkiani, ME |
| 2024-05-23 | Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients. | Zhang, X; Weeramange, CE; Hughes, BGM; Vasani, S; Liu, ZY; Warkiani, M; Hartel, G; Ladwa, R; Thiery, JP; Kenny, L; Breik, O; Punyadeera, C |
| 2021-07-31 | Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer. | Elazezy, M; Schwentesius, S; Stegat, L; Wikman, H; Werner, S; Mansour, WY; Failla, AV; Peine, S; Müller, V; Thiery, JP; Ebrahimi Warkiani, M; Pantel, K; Joosse, SA |
| 2021 | Emerging role of circulating tumor cells in immunotherapy. | Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2022-07-11 | Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics. | Rzhevskiy, AS; Kapitannikova, AY; Vasilescu, SA; Karashaeva, TA; Razavi Bazaz, S; Taratkin, MS; Enikeev, DV; Lekarev, VY; Shpot, EV; Butnaru, DV; Deyev, SM; Thiery, JP; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2021-07 | Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness. | Rozova, VS; Anwer, AG; Guller, AE; Es, HA; Khabir, Z; Sokolova, AI; Gavrilov, MU; Goldys, EM; Warkiani, ME; Thiery, JP; Zvyagin, AV |
| 2020-11-04 | Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells. | Aboulkheyr Es, H; Bigdeli, B; Zhand, S; Aref, AR; Thiery, JP; Warkiani, ME |
| 2021-10-13 | Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs) | Es, HA; Cox, TR; Sarafraz-Yazdi, E; Thiery, JP; Warkiani, ME |
| 2020-07 | Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta. | ABOULKHEYR ESTARABADI, H; Zhand, S; Thiery, JP; Warkiani, ME |
| 2015-06-20 | Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. | Khoo, BL; Lee, SC; Kumar, P; Tan, TZ; Warkiani, ME; Ow, SGW; Nandi, S; Lim, CT; Thiery, JP |
| 2022-09 | Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications. | Radfar, P; Aboulkheyr Es, H; Salomon, R; Kulasinghe, A; Ramalingam, N; Sarafraz-Yazdi, E; Thiery, JP; Warkiani, ME |
| 2019-12-01 | Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions | Azadi, S; Aboulkheyr Es, H; Razavi Bazaz, S; Thiery, JP; Asadnia, M; Ebrahimi Warkiani, M |
